Clinical activity and biomarkers of MEDI4736, an anti-PD-L1 antibody, in patients with NSCLC.

被引：99

作者：

Brahmer, Julie R.

Rizvi, Naiyer A.

Lutzky, Jose

Khleif, Samir

Blake-Haskins, Andy

Li, Xia

Robbins, Paul B.

Vasselli, Jim

Ibrahim, Ramy A.

Antonia, Scott Joseph

机构：

[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Mt Sinai Comprehens Canc Ctr, Miami Beach, FL USA

[4] GRU Canc Ctr, Augusta, GA USA

[5] Medimmune Inc, Gaithersburg, MD 20878 USA

[6] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

来源：

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.3001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8021

引用

页数：1